Estrogen replacement in menopausal women: Recent and current prospective studies, the WHI and the KEEPS

National Center for Health Statistics, 1999, Mortality tables. GMWKHI: Deaths from each cause, by 5-year age groups, Hispanic origin, race for nonHispanic population, and sex: United States, 2002 National Cancer Institute, 1975, Surveillance epidemiology and end results, SEER cancer statistics review Eberhardt, 2001, 189 Eberhardt, 2001, 192 2001 Hodis, 2002, Postmenopausal hormone replacement therapy as antiatherosclerotic therapy, Curr Atheroscler Rep, 4, 52, 10.1007/s11883-002-0062-y Darling, 1997, Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women, N Engl J Med, 337, 595, 10.1056/NEJM199708283370903 Wakatsuki, 2001, Effect of medroxyprogesterone acetate on endotheliumdependent vasodilation in postmenopausal women receiving estrogen, Circulation, 104, 1773, 10.1161/hc4001.097035 Stampfer, 1985, A prospective study of postmenopausal estrogen therapy and coronary heart disease, N Engl J Med, 313, 1044, 10.1056/NEJM198510243131703 Wilson, 1985, Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study, N Engl J Med, 313, 1038, 10.1056/NEJM198510243131702 Bush, 1987, Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study, Circulation, 75, 1102, 10.1161/01.CIR.75.6.1102 Petitti, 1987, Noncontraceptive estrogens and mortality: Long-term followup of women in the Walnut Creek Study, Obstet Gynecol, 70, 289 Boysen, 1988, Stroke incidence and risk factors for stroke in Copenhagen, Denmark, Stroke, 19, 1345, 10.1161/01.STR.19.11.1345 Criqui, 1988, Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community, Am J Epidemiol, 128, 606, 10.1093/oxfordjournals.aje.a115008 Henderson, 1988, Am j Obstet Gynecol, 159, 312, 10.1016/S0002-9378(88)80074-7 van der Giezen, 1990, Systolic blood pressure and cardiovascular mortality among 13,740 Dutch women, Prev Med, 19, 456, 10.1016/0091-7435(90)90043-J Wolf, 1991, Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: Evidence from a national cohort, Am J Obstet Gynecol, 164, 489, 10.1016/S0002-9378(11)80006-2 Falkeborn, 1992, The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement, Br J Obstet Gynaecol, 99, 821, 10.1111/j.1471-0528.1992.tb14414.x Psaty, 1994, The risk of myocardial infarction associated with the combined use of estrogens and progestins in post menopausal women, Arch Intern Med, 154, 1333, 10.1001/archinte.1994.00420120047005 Folsom, 1995, Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women, Am J Public Health, 85, 1128, 10.2105/AJPH.85.8_Pt_1.1128 Grodstein, 1996, Postmenopausal estrogen and progestin use and the risk of cardiovascular disease [published correction appears in N Engl I Med. 1996;335:1406], N Engl J Med, 335, 453, 10.1056/NEJM199608153350701 Colditz, 1995, The use of estrogens and progestins and the risk of breast cancer in postmenopausal women, N Engl J Med., 332, 1589, 10.1056/NEJM199506153322401 Schairer, 2000, Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk [published correc tion appears in LAMA. 2000;284:2597], JAMA, 283, 485, 10.1001/jama.283.4.485 Rossouw, 2002, Risks and benefits of estro gen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001/jama.288.3.321 Silverstein, 1998, Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study, Arch Intern Med, 158, 585, 10.1001/archinte.158.6.585 Grodstein, 2000, A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease, Ann Intern Med, 133, 933, 10.7326/0003-4819-133-12-200012190-00008 Grodstein, 1997, Postmenopausal hormone therapy and mortality, N Engl J Med, 336, 1769, 10.1056/NEJM199706193362501 Hulley, 1998, Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women, JAMA, 280, 605, 10.1001/jama.280.7.605 US Food and Drug Administration, 2003 Scarabin, 2003, Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk, Lancet, 362, 428, 10.1016/S0140-6736(03)14066-4 Pai, 2004, Inflammatory markers and the risk of coronary heart disease in men and women, N Engl J Med, 351, 2599, 10.1056/NEJMoa040967 Hu, 2006, The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: The postmenopausal estrogen progestin intervention (PEPI) trial, Atherosclerosis, 185, 347, 10.1016/j.atherosclerosis.2005.06.011 Anderson, 2004, Effects of conjugated equine estrogen in post menopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial, JAMA, 291, 1701, 10.1001/jama.291.14.1701 Mendelsohn, 2005, Molecular and cellular basis of cardiovascular gender differences, Science, 308, 1583, 10.1126/science.1112062 Raggi, 2000, Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography, Circulation, 101, 850, 10.1161/01.CIR.101.8.850 Clarkson, 1998, Lack of effect of raloxifene on coronary artery atherosclerosis of postmenopausal monkeys, J Clin Endocrinol Metab, 83, 721, 10.1210/jc.83.3.721 Adams, 1997, Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coro nary artery atherosclerosis, Arterioscler Thromb Vasc Biol, 17, 217, 10.1161/01.ATV.17.1.217 Williams, 1995, Regression of atherosclerosis in female monkeys, Arterioscler Thromb Vasc Biol, 15, 827, 10.1161/01.ATV.15.7.827 Manson, 2003, Estrogen plus progestin and the risk of coronary heart disease, N Engl J Med, 349, 523, 10.1056/NEJMoa030808 Hsia, 2006, Conjugated equine estrogens and coronary heart dis ease: The Women's Health Initiative, Arch Intern Med, 166, 357, 10.1001/archinte.166.3.357 Kronos Longevity Research Institute. The Kronos Early Estrogen Prevention Study (KEEPS). Available at: http://www.keepsstudy.org/.